Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression ...

Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...

Popcorn is one of my all-time favorite snacks, especially now that I have to eat gluten-free. It's a quick way to fill me up without having to worry about what's in it. Whether it's buttery movie ...

Interestingly, the uBlock Origin extension installed from the Edge Add-ons store is unaffected. We need to wait and see if this is a Chromium upstream change that affected Edge Canary or if it’s a bug ...

$60 per year for single users; from $70 per year for 2 adults and 4 children $50 per year for single users; has a free Chromium browser; from $80 per year for 5 accounts and 25 devices Neither ...

As the Uniswap price fluctuates, investors are eyeing DeFi tokens for 10x gains in 2025. Remittix, Near Protocol, Uniswap, and Aave stand out as top contenders. Let us highlight each top altcoins ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.